Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals

BACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) is considered first-line therapy for Stenotrophomonas maltophilia infections based on observational data from small studies. Levofloxacin has emerged as a popular alternative due to tolerability concerns related to TMP-SMX. Data comparing levofloxa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarzynski, Sadia H, Warner, Sarah, Sun, Junfeng, Matsouaka, Roland, Dekker, John P, Babiker, Ahmed, Li, Willy, Lai, Yi Ling, Danner, Robert L, Fowler, Vance G, Kadri, Sameer S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794591/
https://www.ncbi.nlm.nih.gov/pubmed/35097154
http://dx.doi.org/10.1093/ofid/ofab644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794591/
https://www.ncbi.nlm.nih.gov/pubmed/35097154
http://dx.doi.org/10.1093/ofid/ofab644

Ejemplares similares